{"id":83786,"date":"2020-10-30T16:00:00","date_gmt":"2020-10-30T16:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2754525"},"modified":"2020-10-30T16:00:00","modified_gmt":"2020-10-30T16:00:00","slug":"intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief","status":"publish","type":"post","link":"http:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/","title":{"rendered":"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief"},"content":{"rendered":"

Comprehensive economic analysis finds no need to halt sales of device at center of patent dispute<\/span><\/strong><\/span><\/p>\n

<\/span>Edwards Lifesciences thwart<\/span>ed<\/span>a<\/span>competitor’s bid for a<\/span><\/span>significant<\/span>temporary restraining order<\/span>and preliminary injunction<\/span><\/span>against<\/span>its<\/span>innovative<\/span>PASCAL heart device<\/span>after<\/span>Intensity and attorneys at Paul, Weiss, Rifkind & Garrison LLP<\/span>present<\/span>ed<\/span>acomprehensive analysis<\/span>refuting<\/span>arguments<\/span>for<\/span>halting sales of the product.<\/span><\/span><\/p>\n

Abbott sought<\/span>a<\/span>TRO<\/span>and preliminary injunction<\/span>in federal court in Delaware<\/span>amid<\/span>a global patent dispute<\/span>over devices used to treat mitral regurgitation, where the leaflets of the mitral valve<\/span>do not<\/span>close tightly<\/span>and<\/span>allow<\/span><\/span>blood to backfill into the heart.<\/span>Abbott claimed PASCAL<\/span>violated several of its patents and was harming sales of its<\/span>competing<\/span><\/span>MitraClip<\/span>.<\/span>Abbott sought injunctive relief and economic damages.<\/span><\/span><\/p>\n

To<\/span>evaluate<\/span>the threatened TRO<\/span>and preliminary injunction<\/span>, Intensity<\/span>e<\/span>conomist<\/span>Dr. Ryan Sullivan prepared<\/span>multiple<\/span>expert reports for courts in the<\/span>United States<\/span>and Ireland,<\/span>and provided live court testimony to examine<\/span><\/span>the economic<\/span>analysis underlying<\/span><\/span>Abbott’s claim it would suffer irreparable harm<\/span>and that<\/span>the public interest and the balance of equities between<\/span>weigh in favor of<\/span>Abbott.<\/span><\/span><\/p>\n

To assess the claim of irreparable harm<\/span>,<\/span>Dr. Sullivan<\/span>determined<\/span>not only the<\/span>types<\/span>of damage Ab<\/span>bot<\/span>t might suffer but whether it could be quantified and compensable. He also<\/span>evaluated<\/span>whether an injunction would<\/span>address<\/span>Abbott’s claimed harms<\/span>and the extent<\/span>of the<\/span>economic relationship between the alleged patent infringement and<\/span>the claimed harms<\/span>.<\/span>“<\/span>The<\/span>multifaceted economics issues combined with the importance of the case to both parties and patients made this an engaging project to apply our rigorous approach<\/span>,<\/span>“<\/span><\/span>Dr.<\/span>Sullivan said<\/span>.<\/span>“<\/span>I am very gratified that our work was a substantial basis for the court’s ruling.”<\/span><\/span><\/p>\n

The public interest was an important consideration, since the dispute involved devices used to treat a common and dangerous heart condition. Intensity conducted market research to determine if PASCAL benefitted patients and whether removing it from the market would<\/span>cause un<\/span>n<\/span>ecessary harm<\/span>. Intensity also weighed the relative hardships Abbott and Edwards would face if the court granted the injunction.<\/span><\/span><\/p>\n

Intensity’s<\/span>economic analysis included an in-depth examination of products in the structural heart device marketplace, market definition, competition, pricing dynamics and<\/span>existing<\/span>licensing agreement<\/span>s<\/span>. Intensity also mapped out product substitution patterns at the customer level to accurately quantify Abbott’s claim<\/span>of<\/span>lost profits.<\/span><\/span><\/p>\n

After considering Intensity’s analysis and the legal arguments of Edwards’ attorneys, U.S. District Judge<\/span>Maryellen<\/span>Noreika<\/span>denied Abbott’s motions for a TRO and a nationwide preliminary injunction. On July 13, Abbott and Edwards announced they had reached a settlement of all disputes involving the mitral regurgitation device patents. Th<\/span>at<\/span>agreement ended parallel litigation in Ireland, where<\/span>Intensity and Dr. Sullivan were<\/span>prepared to present<\/span>their<\/span>analysis again.<\/span><\/span><\/p>\n

<\/span>About Intensity<\/span><\/strong><\/span><\/p>\n

Intensity is a professional services firm that generates powerful research, analysis, and expertise to solve the most complex challenges in the marketplace and courtroom, especially in the areas of economics, finance, and statistics. Using world-class academic training and industry expertise, Intensity professionals conduct thorough research and analysis, develop independent conclusions, and articulate these conclusions in ways that help decision-makers — from corporate executives to judges and juries — make informed decisions. It has built a reputation for unmatched quality, reliability, and responsiveness. The company’s clients include Fortune 500 companies, such as Microsoft, IBM, Novartis, MasterCard, and Adobe.<\/span><\/span><\/p>\n

For more information, please visit http:\/\/www.intensity.com.<\/span><\/span><\/p>\n

Tags: California<\/a>, damages<\/a>, irreparable harm<\/a>, economic<\/a>, Abbot Labs<\/a>, expert witness<\/a>, injunctive relief<\/a>, Edwards Lifesciences<\/a>, Delaware<\/a>, preliminary injunction<\/a>, Economist<\/a>, Professional Services<\/a>, Analysis<\/a>, patent dispute<\/a>, Ryan Sullivan<\/a>, mitral regurgitation<\/a>, Medical<\/a><\/p>\n

See Campaign: <\/strong>http:\/\/intensity.com<\/a>
Contact Information:<\/b>
Melissa Griffiths
\nmelissa.griffiths@intensity.com
\n415-297-7784<\/p>\n

Tags:<\/b>
<\/a>, Financial Content<\/a>, Google News<\/a>, IPS<\/a>, iCN Internal Distribution<\/a>, Extended Distribution<\/a>, Legal Newswire<\/a>, Delaware<\/a>, Healthcare regulations<\/a>, Healthcare<\/a>, California<\/a>, English<\/a><\/p>\n

\"image\"<\/div>\n

\n

Contact Information:<\/h3>\n

Melissa Griffiths
\nmelissa.griffiths@intensity.com
\n415-297-7784<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Comprehensive economic analysis finds no need to halt sales of device at center of patent dispute   Edwards Lifesciences thwarted a competitor’s bid for a significant temporary restraining order and preliminary injunction against its innovative PASCAL heart device after Intensity and attorneys at Paul, Weiss, Rifkind & Garrison LLP presented a comprehensive analysis refuting arguments for halting sales of the product.   Abbott sought a TRO and preliminary injunction in federal court in Delaware amid a global patent dispute over devices used … Continue reading Intensity Client Edwards Lifesciences Defeats Abbott’s Bid For Injunctive Relief<\/span><\/a> Continue Reading →<\/span><\/a><\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81,100,3,5,107,97,48,52,67,57,12],"tags":[],"class_list":["post-83786","post","type-post","status-publish","format-standard","hentry","category-california","category-delaware","category-english","category-extended-distribution","category-financial-content","category-google-news","category-healthcare","category-healthcare-regulations","category-icn-internal-distribution","category-ips","category-legal-newswire"],"yoast_head":"\nIntensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief - Business\" \/>\n<meta property=\"og:description\" content=\"Comprehensive economic analysis finds no need to halt sales of device at center of patent dispute   Edwards Lifesciences thwarted a competitor’s bid for a significant temporary restraining order and preliminary injunction against its innovative PASCAL heart device after Intensity and attorneys at Paul, Weiss, Rifkind & Garrison LLP presented a comprehensive analysis refuting arguments for halting sales of the product.   Abbott sought a TRO and preliminary injunction in federal court in Delaware amid a global patent dispute over devices used … Continue reading Intensity Client Edwards Lifesciences Defeats Abbott’s Bid For Injunctive Relief Continue Reading →\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-30T16:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Law.com Newswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Law.com Newswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/\",\"name\":\"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"datePublished\":\"2020-10-30T16:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/7012fe34f75eda000fbd60128cf39d83\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/7012fe34f75eda000fbd60128cf39d83\",\"name\":\"Law.com Newswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/625c55f2b84c01db10c955086226048e539e0722072d636fb59cec47b21bab02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/625c55f2b84c01db10c955086226048e539e0722072d636fb59cec47b21bab02?s=96&d=mm&r=g\",\"caption\":\"Law.com Newswire\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"http:\/\/ipsnews.net\/business\/author\/law-com-newswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/","og_locale":"en_US","og_type":"article","og_title":"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief - Business","og_description":"Comprehensive economic analysis finds no need to halt sales of device at center of patent dispute   Edwards Lifesciences thwarted a competitor’s bid for a significant temporary restraining order and preliminary injunction against its innovative PASCAL heart device after Intensity and attorneys at Paul, Weiss, Rifkind & Garrison LLP presented a comprehensive analysis refuting arguments for halting sales of the product.   Abbott sought a TRO and preliminary injunction in federal court in Delaware amid a global patent dispute over devices used … Continue reading Intensity Client Edwards Lifesciences Defeats Abbott’s Bid For Injunctive Relief Continue Reading →","og_url":"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/","og_site_name":"Business","article_published_time":"2020-10-30T16:00:00+00:00","author":"Law.com Newswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Law.com Newswire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/","url":"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/","name":"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"datePublished":"2020-10-30T16:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/7012fe34f75eda000fbd60128cf39d83"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2020\/10\/30\/intensity-client-edwards-lifesciences-defeats-abbotts-bid-for-injunctive-relief\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Intensity Client Edwards Lifesciences Defeats Abbott\u2019s Bid For Injunctive Relief"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/7012fe34f75eda000fbd60128cf39d83","name":"Law.com Newswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/625c55f2b84c01db10c955086226048e539e0722072d636fb59cec47b21bab02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/625c55f2b84c01db10c955086226048e539e0722072d636fb59cec47b21bab02?s=96&d=mm&r=g","caption":"Law.com Newswire"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"http:\/\/ipsnews.net\/business\/author\/law-com-newswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/83786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=83786"}],"version-history":[{"count":0,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/83786\/revisions"}],"wp:attachment":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=83786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=83786"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=83786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}